FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4236679102> ?p ?o ?g. }

• W4236679102 endingPage "432" @default.
• W4236679102 startingPage "423" @default.
• W4236679102 abstract "•We report INICC device-associated module data of 45 countries from 2012-2015. •We collected prospective data from 532,483 patients in 523 ICUs for 2,197,304 days. •DA-HAI rates and bacterial resistance were higher in INICC ICUs than in CDC-NHSN's. •Device utilization ratio in the INICC ICUs was similar to CDC-NHSN's. Background We report the results of International Nosocomial Infection Control Consortium (INICC) surveillance study from January 2012 to December 2017 in 523 intensive care units (ICUs) in 45 countries from Latin America, Europe, Eastern Mediterranean, Southeast Asia, and Western Pacific. Methods During the 6-year study period, prospective data from 532,483 ICU patients hospitalized in 242 hospitals, for an aggregate of 2,197,304 patient days, were collected through the INICC Surveillance Online System (ISOS). The Centers for Disease Control and Prevention-National Healthcare Safety Network (CDC-NHSN) definitions for device-associated health care–associated infection (DA-HAI) were applied. Results Although device use in INICC ICUs was similar to that reported from CDC-NHSN ICUs, DA-HAI rates were higher in the INICC ICUs: in the medical-surgical ICUs, the pooled central line-associated bloodstream infection rate was higher (5.05 vs 0.8 per 1,000 central line-days); the ventilator-associated pneumonia rate was also higher (14.1 vs 0.9 per 1,000 ventilator-days,), as well as the rate of catheter-associated urinary tract infection (5.1 vs 1.7 per 1,000 catheter-days). From blood cultures samples, frequencies of resistance, such as of Pseudomonas aeruginosa to piperacillin-tazobactam (33.0% vs 18.3%), were also higher. Conclusions Despite a significant trend toward the reduction in INICC ICUs, DA-HAI rates are still much higher compared with CDC-NHSN's ICUs representing the developed world. It is INICC's main goal to provide basic and cost-effective resources, through the INICC Surveillance Online System to tackle the burden of DA-HAIs effectively. We report the results of International Nosocomial Infection Control Consortium (INICC) surveillance study from January 2012 to December 2017 in 523 intensive care units (ICUs) in 45 countries from Latin America, Europe, Eastern Mediterranean, Southeast Asia, and Western Pacific. During the 6-year study period, prospective data from 532,483 ICU patients hospitalized in 242 hospitals, for an aggregate of 2,197,304 patient days, were collected through the INICC Surveillance Online System (ISOS). The Centers for Disease Control and Prevention-National Healthcare Safety Network (CDC-NHSN) definitions for device-associated health care–associated infection (DA-HAI) were applied. Although device use in INICC ICUs was similar to that reported from CDC-NHSN ICUs, DA-HAI rates were higher in the INICC ICUs: in the medical-surgical ICUs, the pooled central line-associated bloodstream infection rate was higher (5.05 vs 0.8 per 1,000 central line-days); the ventilator-associated pneumonia rate was also higher (14.1 vs 0.9 per 1,000 ventilator-days,), as well as the rate of catheter-associated urinary tract infection (5.1 vs 1.7 per 1,000 catheter-days). From blood cultures samples, frequencies of resistance, such as of Pseudomonas aeruginosa to piperacillin-tazobactam (33.0% vs 18.3%), were also higher. Despite a significant trend toward the reduction in INICC ICUs, DA-HAI rates are still much higher compared with CDC-NHSN's ICUs representing the developed world. It is INICC's main goal to provide basic and cost-effective resources, through the INICC Surveillance Online System to tackle the burden of DA-HAIs effectively." @default.
• W4236679102 created "2022-05-12" @default.
• W4236679102 creator A5000069739 @default.
• W4236679102 creator A5000133652 @default.
• W4236679102 creator A5000180064 @default.
• W4236679102 creator A5000297555 @default.
• W4236679102 creator A5000657333 @default.
• W4236679102 creator A5000724594 @default.
• W4236679102 creator A5000770678 @default.
• W4236679102 creator A5000860997 @default.
• W4236679102 creator A5001071571 @default.
• W4236679102 creator A5001135376 @default.
• W4236679102 creator A5001148114 @default.
• W4236679102 creator A5001161567 @default.
• W4236679102 creator A5001218252 @default.
• W4236679102 creator A5001397951 @default.
• W4236679102 creator A5001418388 @default.
• W4236679102 creator A5001633020 @default.
• W4236679102 creator A5001744087 @default.
• W4236679102 creator A5001774343 @default.
• W4236679102 creator A5001803937 @default.
• W4236679102 creator A5001832864 @default.
• W4236679102 creator A5001917817 @default.
• W4236679102 creator A5001932892 @default.
• W4236679102 creator A5002029757 @default.
• W4236679102 creator A5002030846 @default.
• W4236679102 creator A5002121408 @default.
• W4236679102 creator A5002360720 @default.
• W4236679102 creator A5002414353 @default.
• W4236679102 creator A5002441343 @default.
• W4236679102 creator A5002461158 @default.
• W4236679102 creator A5002533450 @default.
• W4236679102 creator A5002589834 @default.
• W4236679102 creator A5002631213 @default.
• W4236679102 creator A5002648579 @default.
• W4236679102 creator A5003011746 @default.
• W4236679102 creator A5003024680 @default.
• W4236679102 creator A5003314599 @default.
• W4236679102 creator A5003420715 @default.
• W4236679102 creator A5003509827 @default.
• W4236679102 creator A5003767346 @default.
• W4236679102 creator A5003980045 @default.
• W4236679102 creator A5004094141 @default.
• W4236679102 creator A5004149014 @default.
• W4236679102 creator A5004305267 @default.
• W4236679102 creator A5004372254 @default.
• W4236679102 creator A5004477843 @default.
• W4236679102 creator A5004485756 @default.
• W4236679102 creator A5004564904 @default.
• W4236679102 creator A5004566365 @default.
• W4236679102 creator A5004611787 @default.
• W4236679102 creator A5004712122 @default.
• W4236679102 creator A5004798187 @default.
• W4236679102 creator A5004897181 @default.
• W4236679102 creator A5005030971 @default.
• W4236679102 creator A5005206709 @default.
• W4236679102 creator A5005230848 @default.
• W4236679102 creator A5005354678 @default.
• W4236679102 creator A5005373631 @default.
• W4236679102 creator A5005512400 @default.
• W4236679102 creator A5005555345 @default.
• W4236679102 creator A5005582083 @default.
• W4236679102 creator A5005677725 @default.
• W4236679102 creator A5005790998 @default.
• W4236679102 creator A5006012417 @default.
• W4236679102 creator A5006235681 @default.
• W4236679102 creator A5006273158 @default.
• W4236679102 creator A5006366945 @default.
• W4236679102 creator A5006419784 @default.
• W4236679102 creator A5006516308 @default.
• W4236679102 creator A5006698531 @default.
• W4236679102 creator A5006830104 @default.
• W4236679102 creator A5006975892 @default.
• W4236679102 creator A5007055362 @default.
• W4236679102 creator A5007273265 @default.
• W4236679102 creator A5007512337 @default.
• W4236679102 creator A5007601597 @default.
• W4236679102 creator A5007813995 @default.
• W4236679102 creator A5007940431 @default.
• W4236679102 creator A5008105198 @default.
• W4236679102 creator A5008139305 @default.
• W4236679102 creator A5008156811 @default.
• W4236679102 creator A5008165148 @default.
• W4236679102 creator A5008285592 @default.
• W4236679102 creator A5008680164 @default.
• W4236679102 creator A5008685710 @default.
• W4236679102 creator A5008979175 @default.
• W4236679102 creator A5009073716 @default.
• W4236679102 creator A5009124275 @default.
• W4236679102 creator A5009331996 @default.
• W4236679102 creator A5009374192 @default.
• W4236679102 creator A5009444295 @default.
• W4236679102 creator A5009569793 @default.
• W4236679102 creator A5009624721 @default.
• W4236679102 creator A5009839033 @default.
• W4236679102 creator A5009896310 @default.
• W4236679102 creator A5009925535 @default.
• W4236679102 creator A5009955319 @default.

• next